-
Sorafenib Beyond the Kinase Panel
2026-09-26
Sorafenib is more than a kinase inhibitor to add to a screening panel: it is a research probe for connecting RAF-dependent tumor-cell signaling with VEGFR-linked angiogenesis. This article considers how to use BAY-43-9006 to build stronger, more translational experiments—and how emerging VEGFR-2 inhibitors can sharpen that strategy.
-
EZ Cap™ CPF1/Cas12a mRNA: Reading the Editing Window
2026-09-26
EZ Cap™ CPF1/Cas12a mRNA (m1Ψ) is a Cas12a-encoding research reagent for CRISPR genome editing. This article explains how to interpret editing as a time-dependent process shaped by target-site architecture, guide performance, and DNA repair—not simply nuclease delivery.
-
3-Deazaneplanocin A hydrochloride: DZNep Workflows
2026-09-25
Use DZNep to test how EZH2-associated repression and H3K27me3 relate to cell fate, proliferation, and apoptosis—while distinguishing broad chromatin perturbation from locus-specific restoration. This guide outlines practical dose-and-time workflows for AML and metabolic studies, plus cautious ways to interpret experiments in human pluripotent stem cells.
-
Thioguanine Workflows for Cancer and EV71 Assays
2026-09-25
Thioguanine supports distinct in-vitro oncology and EV71 research questions, with reported activity across cancer cell models and an EV71 assay in HT-29 cells. This workflow guide shows how to prepare the compound, choose complementary readouts, and avoid mistaking cytotoxicity or model-specific results for a universal mechanism.
-
mCherry mRNA for Nanoparticle Workflow Validation
2026-09-24
Use red fluorescent protein mRNA to track functional delivery, compare formulation conditions, and optimize reporter assays without confusing particle uptake with successful protein expression. EZ Cap™ mCherry mRNA (5mCTP, ψUTP) combines Cap 1, modified nucleotides, and a poly(A) tail for a practical fluorescent readout in cell-based workflows.
-
Anagliptin Relaxes Rabbit Aorta via Kv and SERCA
2026-09-24
A rabbit-aorta study reports that anagliptin relaxes phenylephrine-contracted vessels through mechanisms involving voltage-dependent potassium channels and the SERCA pump. Its inhibitor-based experiments distinguish these effects from several other potassium-channel classes, cyclic-nucleotide pathways, and endothelial signaling, while leaving direct molecular targets and clinical relevance unresolved.
-
Ibrexafungerp: Assay Workflows for Resistant Candida
2026-09-23
Ibrexafungerp, also known as MK 3118, combines oral delivery with activity against resistant Candida and retains in vitro potency under acidic conditions relevant to vulvovaginal candidiasis. This practical guide translates the key pH-susceptibility finding into reproducible broth microdilution, model-selection, and troubleshooting workflows.
-
GA/PPC Lipid Nanoparticles for p65 siRNA Delivery
2026-09-23
The reference study developed glycyrrhizic acid and polyene phosphatidylcholine-modified lipid nanoparticles for delivering p65 siRNA in acute liver injury. Its central contribution is the combination of nucleic-acid delivery with formulation components intended to improve cellular uptake, gene silencing, siRNA stability, and tolerability, while also providing evidence that the platform can deliver other oligonucleotide cargos.
-
Standardized Whole-Blood Stimulation and Immunometabolism
2026-09-22
The reference protocol establishes a standardized whole-blood platform for measuring how immune stimuli and metabolic interventions jointly shape cytokine responses. Its main contribution is methodological: it preserves a complex human blood environment while organizing stimulation, metabolic modulation, controls, and cytokine quantification for reproducible cohort studies and mechanistic immunology.
-
Hexetidine: Context-Aware Oral Antimicrobial Assays
2026-09-21
Hexetidine (NSC-17764) behaves differently across broth, protein-rich saliva, and oral biofilm models. This evidence-led guide explains how matrix effects, endpoint selection, formulation, and residual activity should shape antimicrobial assay design and interpretation.
-
Nystatin (Fungicidin) Research Workflows
2026-09-21
Build reproducible Candida, mycoplasma, adhesion, and delivery assays with Nystatin (Fungicidin), while controlling its solvent sensitivity and membrane-active behavior. The workflow also shows how nanoparticle size, surface chemistry, and uptake measurements can inform—but not replace—direct antifungal validation.
-
ABT-263 (Navitoclax) Apoptosis Workflow
2026-09-20
Learn how ABT-263 (Navitoclax) can distinguish apoptosis-prone, DNA-damage-induced senescence from reversible treatment-associated growth arrest. This practical workflow combines dose planning, mitochondrial priming, apoptosis assay selection, and troubleshooting for cancer biology studies.
-
EZ Cap™ Human PTEN mRNA: Applied Workflows
2026-09-19
Use Cap 1, poly(A)-tailed PTEN mRNA to model pathway rescue, optimize delivery vehicles, and test localized cancer interventions. This practical guide connects controlled cell experiments with the HA-LNP strategy reported for transdermal melanoma research.
-
Cy5.5 NHS Ester for NIR Biomolecule Imaging
2026-09-19
Cy5.5 NHS ester enables covalent near-infrared labeling of amino-bearing proteins, peptides, and modified nucleic acids for sensitive assay development. This guide combines solvent-aware conjugation, purification, imaging controls, and a practical translation of recent polysaccharide biodistribution research.
-
Hypothermic Albumin Perfusion in Stroke
2026-09-18
The reference study presents intra-arterial selective cooling human serum albumin infusion as a targeted strategy for reducing cerebral ischemia-reperfusion injury after middle cerebral artery occlusion. In rats, the combined intervention outperformed selective cooling saline, saline alone, and albumin alone, with benefits linked to lower neuroinflammation, improved neurological recovery, and preservation of blood-brain barrier integrity.